Serina Therapeutics, Inc. Shares Outstanding (Cover Page)
Serina Therapeutics, Inc. (SER) had Shares Outstanding (Cover Page) of 25.40 million shares as of 2026-08-10, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-10: Entity Common Stock, Shares Outstanding 25.40M shares.
- 2026-05-10: Entity Common Stock, Shares Outstanding 15.00M shares.
- 2026-03-18: Entity Common Stock, Shares Outstanding 12.31M shares.
- 2025-11-10: Entity Common Stock, Shares Outstanding 10.66M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-10 | 25.40M shares 10-Q · filed 2026-08-13 |
| 2026-05-10 | 15.00M shares 10-Q · filed 2026-05-14 |
| 2026-03-18 | 12.31M shares 10-K/A · filed 2026-03-27 |
| 2025-11-10 | 10.66M shares 10-Q · filed 2025-11-13 |
| 2025-08-08 | 10.25M shares 10-Q · filed 2025-08-11 |
| 2025-05-06 | 9.97M shares 10-Q · filed 2025-05-08 |
| 2025-03-20 | 9.93M shares 10-K · filed 2025-03-24 |
| 2024-11-07 | 8.89M shares 10-Q · filed 2024-11-12 |
| 2024-08-05 | 8.88M shares 10-Q · filed 2024-08-09 |
| 2024-05-09 | 8.41M shares 10-Q · filed 2024-05-14 |
| 2024-03-14 | 2.50M shares 10-K · filed 2024-03-22 |
| 2023-11-06 | 37.95M shares 10-Q · filed 2023-11-14 |
| 2023-08-08 | 37.95M shares 10-Q · filed 2023-08-14 |
| 2023-05-05 | 37.95M shares 10-Q · filed 2023-05-12 |
| 2023-03-20 | 37.95M shares 10-K · filed 2023-03-31 |
| 2022-11-07 | 37.95M shares 10-Q · filed 2022-11-10 |
| 2022-08-05 | 37.95M shares 10-Q · filed 2022-08-12 |
| 2022-05-06 | 37.94M shares 10-Q · filed 2022-05-13 |
| 2022-03-14 | 37.94M shares 10-K · filed 2022-03-29 |
| 2021-11-10 | 37.94M shares 10-Q · filed 2021-11-12 |
| 2021-08-10 | 37.94M shares 10-Q · filed 2021-08-13 |
| 2021-05-12 | 37.94M shares 10-Q · filed 2021-05-17 |
| 2021-03-26 | 37.94M shares 10-K · filed 2021-03-31 |
| 2020-11-13 | 37.69M shares 10-Q · filed 2020-11-16 |
| 2020-08-12 | 37.69M shares 10-Q · filed 2020-08-14 |
| 2020-05-12 | 37.66M shares 10-Q · filed 2020-05-14 |
| 2020-03-16 | 37.66M shares 10-K/A · filed 2020-03-31 |
| 2019-11-12 | 37.65M shares 10-Q · filed 2019-11-14 |
| 2019-08-06 | 37.63M shares 10-Q · filed 2019-08-14 |
| 2019-05-10 | 37.63M shares 10-Q · filed 2019-05-15 |
| 2019-03-19 | 37.63M shares 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |